Stada And Xbrane Gain EU All-Clear For Ranibizumab Biosimilar
Companies Aim To Launch Lucentis Rival In Selected European Markets Early Next Year
A formal European marketing authorization approval has now been granted • Source: Deco / Alamy Stock Photo 
